EnClear Therapies, Inc.
65 Parker Street #3A. Newburyport, MA 01950

©2018 by EnClear Therapies. Proudly created with Wix.com

The EnClear Team

Management Team

CEO, Co-Founder

Anthony R. DePasqua

•20yrs Med Tech Experience
•Business & Product Dev, Marketing & Sales, Portfolio Strategy
•Developed & Launched Platform Tech, Disposables & Services
•Neuro, Ortho & Oncology

Scientific Advisory Board

Kevin Eggan, Ph.D.

Professor of Stem Cell and Regenerative Biology at Harvard University

Clifford Woolf, Ph.D.

Director FM Kirby Neurobiology Center at Children's Hospital Boston

Manuel Navia, Ph.D.

Founder & President, Hub-Bio Strategic Advising

Bernhardt Trout, Ph.D.

Raymond F. Baddour, ScD, (1949) Professor of Chemical Engineering, MIT and Member of the Advisory Board at Hedgeness

Clinical Advisory Board

William Brian Gormley, MD, MPH, MBA

Director. Neurosurgical Critical Care, BWH

Assistant Professor of Surgery. Harvard Medical School

Josh Vose, MD, MBA

Medical Director, Medical and Clinical Affairs Professional, Physician and Engineer

Board Of Directors

Jonathan Fleming, M.P.A.


Anthony R. DePasqua

President & CEO

EnClear Therapies

Hillel Bachrach

Managing Partner

20/20 HealthCare Partners

Jason Camm

Managing Director & Chief Medical Officer

Thiel Capital

Kasper Roet, Ph.D.



Gladys Nunez (Observer)


Amgen Ventures at Amgen